🇺🇸 FDA

Intelligence Platform

Patents

Browse 6 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12419955

Method for efficiently infecting human natural killer cells and other immune cells with ps

Beijing Gene MINK Biotechnology CO.LTD · Granted Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12391741

T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and me

MiNK Therapeutics, Inc. · Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11898165

Engineered host cells and methods of use thereof

MiNK Therapeutics, Inc. · Granted Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11718658

T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and me

MiNK Therapeutics, Inc. · Granted Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11613764

T cell receptors that bind to NY-ESO-1 and methods of use thereof

MiNK Therapeutics, Inc. · Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9943496

Dietary supplement based on ethyl ferulate

LABORATORIOS MINKAB, S.A. DE C.V. · Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted